Medicine & Health

Nautral killer (NK) cells may be more effective as immunotherapy for cancer treatment than adult NK cells that come from bone marrow, according to a new study from the School of Medicine.

Researchers at Washington University School of Medicine and Mayo Clinic in Rochester, Minn., have found — in newborn mice — that a component of breast milk may help protect premature babies from developing life-threatening sepsis.

Soon after a novel coronavirus first appeared, School of Medicine researchers, doctors and staff began preparing for a possible outbreak. Infectious disease physicians started planning how to respond, and researchers got to work finding drugs or vaccines for COVID-19.

A mouse study from Washington University School of Medicine in St. Louis suggests a type of immune cell may play a surprising role in the structure and rhythm of the heart.

A drug strategy aimed at revving up the immune system and boosting a type of immune cell known as natural killer cells appears, at least in mice, to effectively treat the skin condition eczema. A team led by the School of Medicine’s Brian S. Kim, MD, is behind the strategy.

Jeffrey R. Millman and his team at the Washington University School of Medicine produced human insulin-secreting beta cells from stem cells using a new efficient technique. The cells were able to rapidly cure diabetes in mice for at least nine months.

Studying mice, researchers at the School of Medicine and their colleagues have shown that a drug compound can block damage caused by too much glutamate signaling, raising the possibility of medication that prevents noise-induced hearing loss.

A new study led by the School of Medicine lays out a genetic road map of immune responses to tuberculosis (TB) infection across three species.

New research led by the School of Medicine indicates that 1 in 4 of the children given antibiotics in U.S. children’s hospitals are prescribed the drugs inappropriately. The overuse of antibiotics poses an increasing threat to children who develop — or already have — drug-resistant infections.

Timothy Miller, MD, PhD, the David Clayson Professor of Neurology at Washington University School of Medicine in St. Louis, and a group of his colleagues have received the inaugural Healey Center International Prize for innovation in amyotrophic lateral sclerosis (ALS) research from the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital.